Incidental Skin Cancer Detection in a Hospital Department: A Prospective Study

Vila-Payeras, Aina; Domínguez‐Mahamud, Carolina; Truyols, Amador Solá; Nadal, Cristina; Taberner, R.

doi:10.1016/j.adengl.2020.04.013

Cited by 3 publications

(6 citation statements)

References 13 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Besides this, GPs may have been more reserved in referring patients with a suspected BCC compared to patients with a suspected cSCC. Moreover, compared to cSCCs, BCCs are more often detected incidentally during the examination of a patient referred to a dermatologist for a different reason 16–18 . The overall decline in dermatology consultations has likely reduced the number of these incidental finds, thereby contributing to a stronger decline in BCC diagnoses.…”

Section: Discussionmentioning

confidence: 99%

“…Moreover, compared to cSCCs, BCCs are more often detected incidentally during the examination of a patient referred to a dermatologist for a different reason. [16][17][18] The overall decline in dermatology consultations has likely reduced the number of these incidental finds, thereby contributing to a stronger decline in BCC diagnoses. This is supported by the steep decline in BCC diagnoses that was observed as soon as the number of dermatology consultations started to decline.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

The impact of the COVID‐19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

Slotman

Schreuder

Nijsten

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

Background The COVID-19 pandemic impacted Dutch society and the healthcare system. Focus switched to care for COVID-19 patients, thereby altering care for non-COVID patients. Non-urgent medical visits were cancelled or postponed and patients were reluctant to visit healthcare services.Objectives This study aimed to investigate the impact of the COVID-19 pandemic on trends in diagnoses of keratinocyte carcinoma (cutaneous squamous cell carcinoma (cSCC), basal cell carcinoma (BCC)) and to assess the magnitude of diagnostic delays. MethodsThe number of cSCC and BCC diagnoses in each month of 2020 was compared to the expected number of diagnoses for these months, using data from the Netherlands Cancer Registry. Expected diagnoses for 2020 were used as a reference to take the yearly increase in keratinocyte carcinoma incidence into account and were calculated by extrapolating the trends observed in 2017-2019. Comparisons were further stratified by age, sex and region. Estimates of diagnostic delays were calculated and corrected for the influence of excess mortality due to the pandemic on keratinocyte carcinoma incidence. ResultsThe number of cSCC and BCC diagnoses substantially decreased when compared to the number of diagnoses expected from March to May 2020 (cSCC À29%, BCC À50%). These decreases were observed across all age groups, both sexes, and all regions. From June to September the number of cSCC and BCC diagnoses was higher than expected, after which it slightly dropped below expected in October to December. In total, 2020 keratinocyte carcinoma diagnoses continued to trail those expected, with a backlog of around 1150 cSCCs and 11 767 BCCs remaining at the end of the year. ConclusionDiagnosis of keratinocyte carcinoma was suboptimal during the COVID-19 pandemic, due to diagnostic delays likely resulting from both patient and health system-related delay. Further studies will need to determine the effects of these diagnostic delays on outcomes.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

The impact of the COVID‐19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

Slotman

Schreuder

Nijsten

et al. 2022

Acad Dermatol Venereol

View full text Add to dashboard Cite

show abstract

“…47 Lastly, BCC is often diagnosed incidentally during whole body skin examinations, which were less frequent during the pandemic. 50,51 Higher cSCC and NMSC incidence rate ratios were observed in 2021 compared with 2020, suggesting a trajectory towards pre-pandemic levels of healthcare service provision. This trend is supported by WHO data which indicated reduced excess mortality in 2021, a measure used to assess the impact of the COVID-19 pandemic.…”

Section: Discussionmentioning

confidence: 99%

“…Furthermore, BCC's slower development and less symptomatic growth than cSCC could have led to fewer individuals seeking medical attention 47 . Lastly, BCC is often diagnosed incidentally during whole body skin examinations, which were less frequent during the pandemic 50,51 …”

Section: Discussionmentioning

confidence: 99%

Impact of the COVID‐19 pandemic on international cutaneous squamous cell carcinoma incidence: A systematic review and meta‐analysis

Wall,

Gadsby‐Davis,

Mistry

et al. 2024

Skin Health and Disease

View full text Add to dashboard Cite

BackgroundNon‐melanoma skin cancer (NMSC) is the most common cancer globally in white ethinicity populations, and cutaneous squamous cell carcinoma (cSCC) is the second most common subtype. The COVID‐19 pandemic severely impacted public and private healthcare systems. Many studies have reported reduced cancer diagnoses during the pandemic. The impact of the COVID‐19 pandemic on global cSCC and NMSC incidence is poorly reported.ObjectivesThe aim was to conduct a systematic review and meta‐analysis to assess the impact of the COVID‐19 pandemic on global cSCC and NMSC incidence rates, compared with 2019 incidence rates. Two primary outcome measures were used: crude incidence rate ratios (CIRR) and age‐standardised incidence rate ratios (ASIRR).MethodsA structured search was undertaken on 23 March 2023 using grey literature and four electronic databases: MEDLINE, CINAHL, EMBASE and Web of Science. Studies published before January 2020 were excluded. A quality assessment was undertaken using A. Lomas quality assessment tool. CIRR outcomes were synthesised in a meta‐analysis, while ASIRR outcomes were narratively synthesised.ResultsFourteen cancer registries were included, capturing data from 13 countries across Europe. Variation was observed in NMSC and cSCC incidence across the cancer registries. Pooled cSCC crude incidence rates in 2020 were equal to crude incidence rates in 2019 (cSCC‐CIRR 1.00 (95% confidence interval (CI) 0.94–1.06). In 2021, the pooled result indicated a non‐significant 8% increase in cSCC crude incidence rates, compared with 2019 (cSCC‐CIRR 1.08 (95% CI 0.98–1.19). Significant reductions were reported in NMSC incidence across all meta‐analyses in 2020 and 2021 compared with 2019. Heterogeneity was observed across most pooled estimates (I2>75%).ConclusionThere was a lack of high quality data on cSCC incidence rates recorded during the pandemic outside of Europe. The COVID‐19 pandemic resulted in no significant changes in cSCC incidence across Europe. By contrast, NMSC incidence fell across Europe following the pandemic. Significant reductions in pooled NMSC incidence rates may reflect a delay in basal cell carcinoma presentation, diagnosis and treatment. Although annual incidence rates for cSCC were not affected by the pandemic, delays in treatment may still have occurred, which may result in poorer outcomes yet to be fully understood.

show abstract

“…Three dermatologists, who provided general dermatology consultations, took part in the study. They carried out a physical examination in response to the reason for each patient’s consultation, which thus varied according to each researcher, his or her age or personal history, but without being required by protocol to carry out a complete exploration of all the subjects ( 11 ). The following data were taken from each of the patients: type of tumour, its size, location, period of evolution, presence of associated symptoms, and whether the lesion was the reason for the consultation or was detected incidentally.…”

Section: Methodsmentioning

confidence: 99%

Development of a Prediction Model for Patients at Risk of Incidental Skin Cancer: A Multicentre Prospective Study

Iglesias‐Puzas

Conde‐Taboada²,

Aranegui-Arteaga³

et al. 2021

Acta Derm Venereol

View full text Add to dashboard Cite

Incidental skin cancer diagnosed in routine dermatology consultations represents a significant proportion of the total diagnosed. This study contributes to current strategies to improve early diagnosis of cancer, by highlighting factors that can trigger or act as barriers to skin cancer detection and seeking consultation. Incidental skin cancer appears to be related to both patient and tumour characteristics, with symptoms, time of evolution, family history of skin cancer, sex and living alone being the major contributors to patients taking notice of any changes or newly appearing skin lesions.In the absence of guidelines recommending routine total-body skin examination, patient concern remains the main factor in seeking consultation regarding suspicion of skin cancer. This study explores gaps in patients' understanding of malignant skin lesions, through the factors associated with incidental skin cancer. Included patients had a confirm ed histological diagnosis of basal cell carci noma, squamous cell carcinoma or melanoma. Tumour characteristics, patient demographics and other risk factors related to the development of skin cancer were obtained from each participant. The main measure was incidental skin cancer detection, using both binary logistic regression and Chi-squared Automatic Interaction Detection (CHAID) algorithm. Of the total tumours, 26.6% were detected incidentally. The following variables: male sex, living alone, long-axis diameter, tumour location, symptoms and time of disease evolution were independent predictors of incidental skin cancer. According to the CHAID algorithm, the most significant risk factor for incidental skin cancer was the absence of symptoms at diagnosis.

show abstract

Incidental Skin Cancer Detection in a Hospital Department: A Prospective Study

Cited by 3 publications

References 13 publications

The impact of the COVID‐19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

The impact of the COVID‐19 pandemic on keratinocyte carcinoma in the Netherlands: Trends in diagnoses and magnitude of diagnostic delays

Impact of the COVID‐19 pandemic on international cutaneous squamous cell carcinoma incidence: A systematic review and meta‐analysis

Development of a Prediction Model for Patients at Risk of Incidental Skin Cancer: A Multicentre Prospective Study

Contact Info

Product

Resources

About